最近和预期的新药批准为2023年和2024年
Matthew H Rim1, Brittany L Karas1, Farah Barada1
1Northwestern Medicine, Chicago, IL, USA.
概括
药剂师可以为即将到来的新药批准做好准备,包括细胞和基因疗法,影响瘤学,传染病和罕见疾病. 这一审查有助于管理医院配方和临床计划.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健系统 药房 药房
- 药物开发 药物开发
背景情况:
- 医疗系统药剂师对于管理药物配方和优化临床计划至关重要.
- 监测制药管道对于资源配置和战略规划至关重要.
研究的目的:
- 为医疗系统药剂师提供预计在未来12个月内获得新药批准的最新信息.
- 支持药剂师准备具有重大临床和财务影响的新疗法.
主要方法:
- 对预计在2023年第四季度和2024年第三季度之间获得FDA批准的新药的审查.
- 分析的重点是药物在医院和诊所设置潜在的影响.
主要成果:
- 制药管道包括58种预期批准的新药.
- 主要的治疗领域包括瘤学,传染病 (例如,复杂的尿路感染,肺炎) 和罕见疾病.
- 新兴的治疗方法,如细胞和基因疗法,已被用于遗传疾病,罕见疾病和癌症.
结论:
- 预期的药物批准涉及多种迹象,包括肺动脉高血压,慢性阻塞性肺病,糖尿病和肥胖症.
- 细胞和基因疗法是治疗复杂疾病的不断增长的创新领域.
- 药剂师应该保持有关这些管道药物的信息,以优化患者护理和资源管理.
更多相关视频
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.1K
09:55Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
Published on: October 4, 2024
396
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Nomenclature
1.8K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.8K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Prescription, Nonprescription and Orphan Drugs
736
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
736
Drug Administration and Therapy Phases: Overview
475
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
475
